Showing results (211-220 of 225) with videos related to

Sort By:
Pageof 23
Annals of the Rheumatic Diseases|October 16, 2009
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registryX Mariette, F Tubach, H Bagheri, et al.
Cancer Detection and Prevention|January 1, 1992
Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisoneI Blazsek, M Musset, D Boulé, et al.
RMD Open|September 22, 2016
Association between RANK, RANKL and OPG polymorphisms with ACPA and erosions in rheumatoid arthritis: results from a meta-analysis involving three French cohortsAdeline Ruyssen-Witrand, Yannick Degboé, A Cantagrel, et al.
Arthritis Care & Research|June 12, 2013
Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: data from the autoimmunity and rituximab registryS Godot, J-E Gottenberg, S Paternotte, et al.
HIV Medicine|November 17, 2004
Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002)K Martin, S Lawson-Ayayi, G Miremont-Salamé, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Monocytic origin of fibroblasts: spontaneous transformation of blood monocytes into neo-fibroblastic structures in osteomyelosclerosis and Engelmann's diseaseM L Labat, A F Bringuier, C Séébold, et al.
Arthritis and Rheumatism|May 28, 2010
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registryJ-E Gottenberg, P Ravaud, T Bardin, et al.
Arthritis Care & Research|August 27, 2010
Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registryB Terrier, D Launay, G Kaplanski, et al.
Cancer Immunology, Immunotherapy : CII|March 19, 2022
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitorsE Gefard-Gontier, R Markich, M Zysman, et al.
Annals of the Rheumatic Diseases|May 23, 2012
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registryJ E Gottenberg, P Ravaud, A Cantagrel, et al.
Pageof 23